IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 18 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,281,500 | -4.2% | 9,500,000 | 0.0% | 0.05% | 0.0% |
Q2 2023 | $9,684,775 | +2.0% | 9,500,000 | 0.0% | 0.05% | +4.3% |
Q1 2023 | $9,495,440 | -9.0% | 9,500,000 | 0.0% | 0.05% | -6.1% |
Q4 2022 | $10,437,460 | +7.4% | 9,500,000 | 0.0% | 0.05% | +11.4% |
Q3 2022 | $9,722,000 | -4.8% | 9,500,000 | 0.0% | 0.04% | 0.0% |
Q2 2022 | $10,215,000 | -9.4% | 9,500,000 | 0.0% | 0.04% | +4.8% |
Q1 2022 | $11,276,000 | +4.0% | 9,500,000 | 0.0% | 0.04% | +2.4% |
Q4 2021 | $10,840,000 | -5.6% | 9,500,000 | 0.0% | 0.04% | -18.0% |
Q3 2021 | $11,484,000 | +0.8% | 9,500,000 | 0.0% | 0.05% | -3.8% |
Q2 2021 | $11,397,000 | +6.0% | 9,500,000 | 0.0% | 0.05% | -11.9% |
Q1 2021 | $10,748,000 | +0.6% | 9,500,000 | 0.0% | 0.06% | -4.8% |
Q4 2020 | $10,688,000 | +13.7% | 9,500,000 | 0.0% | 0.06% | +1.6% |
Q3 2020 | $9,404,000 | – | 9,500,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAMDEN ASSET MANAGEMENT L P /CA | 36,225,000 | $40,606,000 | 1.41% |
Context Capital Management, LLC | 3,000,000 | $3,378,000 | 0.46% |
SHENKMAN CAPITAL MANAGEMENT INC | 3,808,000 | $4,308,000 | 0.45% |
AQR Arbitrage LLC | 7,500,000 | $8,444,000 | 0.30% |
Polar Asset Management Partners Inc. | 14,500,000 | $16,367,000 | 0.18% |
LINDEN ADVISORS LP | 9,300,000 | $10,496,000 | 0.08% |
Calamos Advisors LLC | 9,500,000 | $10,688,000 | 0.06% |
Jefferies Group LLC | 2,201,000 | $2,502,527 | 0.02% |
Citadel Advisors | 62,788,000 | $71,391,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 10,000,000 | $11,259,000 | 0.01% |